Description
Cambridge The Moral Corporation Merck Experiences by P. Roy Vagelos , Louis Galambos
Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded. Preface; Introduction; Part I. Conceptual Grounding and Policy Context: 1. Student diversity and science outcomes; 2. Conceptual frameworks and educational policies; Part II. Student Learning and Classroom Practices: 3. Students and science learning; 4. Science curriculum; 5. Science instruction; 6. Science assessment; Part III. Creating Equitable Learning Environments: 7. Teacher education; 8. School organization and educational policies; 9. School and home/community connections; Part IV. Conclusions and a Research Agenda: 10. Conclusions; 11. Research agenda; Appendix: Method for research synthesis; References.